Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 9:55 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 41 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Routine Infection control Clear all

Conditions: Benign Pancreatic Neoplasm, Malignant Pancreatic Neoplasm
Interventions: Biospecimen Collection, Laboratory Procedure, Nanopore Sequencing; Procedure · Other · Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Candida Auris Infection, Colonization, Asymptomatic
Interventions: Povidone Iodine Topical; Drug
Lead sponsor: Mary K Hayden; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 3
States / cities: Chicago, Illinois • Hinsdale, Illinois

Conditions: Infection Control, Surgical Site Infection
Interventions: Intervention Cluster; Other
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Chlamydia, Gonorrhea, HIV
Interventions: HIV testing, STI/HIV-T, STI/HIV-Plus; Behavioral
Lead sponsor: North Bronx Healthcare Network; Other
Eligibility: 14 Years to 21 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Treponema Pallidum Infection, Chlamydia Trachomatis Infection, Neisseria Gonorrheae Infection, Trichomonas Vaginalis Vaginitis, Sexually Transmitted Infection
Interventions: Point-of-care STI tests, Standard of care STI testing; Diagnostic Test
Lead sponsor: Emory University; Other
Eligibility: Female only
Enrollment: 756 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Pneumococcal Immunization, Healthy Volunteers
Interventions: PCV21 vaccine, 20vPCV licensed vaccine; Biological
Lead sponsor: Sanofi; Industry
Eligibility: 42 Days to 89 Days
Enrollment: 2,195 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 14
States / cities: Fayetteville, Arkansas • Huntington Park, California • Los Angeles, California + 10 more

Conditions: Healthcare Associated Infections, Methicillin Resistant Staphylococcus Aureus, Multi Drug Resistant Organisms
Interventions: Arm 2: Decolonization; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 12 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 52
States / cities: West Hills, California • Thornton, Colorado • Bradenton, Florida + 42 more

Conditions: Urinary Tract Infections, Vaginal Flora Imbalance
Interventions: BioNourish; Device
Lead sponsor: Vaginal Biome Science; Other
Eligibility: Up to 89 Years · Female only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Solid Tumor, Adult, Healthy Donors, COVID-19 Donors
Interventions: Not listed
Lead sponsor: BioCytics, Inc.; Industry
Eligibility: 5 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2030
U.S. locations: 1
States / cities: Huntersville, North Carolina

Conditions: Surgical Site Infection
Interventions: IrriSept System, No Intervention - Standard of Care (SoC) only; Device · Other
Lead sponsor: Irrimax Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 627 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 17
States / cities: Tucson, Arizona • Los Angeles, California • Denver, Colorado + 14 more

Conditions: Burns, Wound Infection
Interventions: Methylene Blue, Blue Light Illumination; Drug · Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Central Line Associated Bloodstream Infections (CLABSI), Bone Marrow Transplant
Interventions: Parafilm; Device
Lead sponsor: Emory University; Other
Eligibility: Up to 21 Years
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Prolapse, Stress Urinary Incontinence
Interventions: Preoperative telephone call three days before surgery; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years and older · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Austin, Texas

Conditions: Spirometry
Interventions: Community health worker-delivered multi-component respiratory health intervention; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 9 Years and older
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Corneal Ulcer, Infectious Keratitis, Bacterial Ulcer, Fungal Ulcer
Interventions: Corneal Cross-linking, Anti Fungal Drug; Procedure · Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: HIV Infections, Inpatient Facility Diagnoses
Interventions: Team Based Inpatient ARTAS, Standard of Care; Behavioral
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Kidney Stone, Renal Stone, Infection, Bacterial
Interventions: NGS + Antibiotic Recommendation, Standard of Care treatment; Other · Procedure
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 3
States / cities: San Antonio, Texas

Conditions: Latent Tuberculosis
Interventions: Usual Care, Video Directly Observed Therapy alone, Video Directly Observed Therapy plus Financial Incentives; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 399 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions: Endoscopy tissue collection; Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Allogeneic Hematopoietic Stem Cell
Interventions: fecal microbiota transplantation (FMT), No fecal microbiota transplantation (FMT), routine management; Biological · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Kidney Transplant Immunosuppression
Interventions: adjustment of immunosuppressant dosages, adjustment of the dosages of immunosuppressants; Drug
Lead sponsor: CAMC Health System; Other
Eligibility: 18 Years to 80 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Charleston, West Virginia

Conditions: Bacterial Vaginosis
Interventions: Flourish HEC Vaginal Care System; Device
Lead sponsor: Vaginal Biome Science; Other
Eligibility: 18 Years to 52 Years · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Alcohol Use Disorder, Liver Transplant; Complications
Interventions: Acamprosate; Drug
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: HIV Infections
Interventions: Couples HIV testing and counseling, Individual HIV testing and counseling; Behavioral
Lead sponsor: Hunter College of City University of New York; Other
Eligibility: 17 Years to 65 Years · Male only
Enrollment: 384 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Ann Arbor, Michigan • New York, New York

Search by objective public record fields.

"Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures

Nasal Antisepsis for C. Auris Prevention

Early Recognition and Response to Increases in Surgical Site Infections Using Optimized Statistical Process Control Charts: The Early 2RIS Study

Project AWARE: Using the Emergency Department (ED) to Prevent Sexually Transmitted Infections (STIs) in Youth

Improving Maternal and Child Health Through Point-of-care STI Testing

Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

Active Bathing to Eliminate Infection (ABATE Infection) Trial

Vaginal Care System for Menopausal Women With Urinary Tract Infections

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

Irrisept Versus Standard of Care in the Prevention of Surgical Site Infections

Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection

Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT

Telephone Intervention to Increase Patient Preparedness and Satisfaction Trial (TIPPS): A Randomized Control Trial

The INTERvening for LUNG Health Trial

Cross-linking for Corneal Ulcers Treatment Trial

Teamwork Makes the Dream Work

Antibiotic Selection Using Next Generation Sequencing vs Urine Culture

Economic Incentives and vDOT for Latent Tuberculosis Infection

Changes Associated With H. Pylori and Gastric Carcinogenesis

Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient

Effect of Flourish HEC Vaginal Care System on BV Recurrence and the Vaginal Microbiome

Safety of Acamprosate in Treating Alcohol Use Disorder in the Post Liver Transplant Populations

Evaluating the Efficacy of Annual CHTC Retesting Among Male Couples at High Risk of HIV Infection